ArticleResearch and practice in thrombosis and haemostasis2026

Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial.

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.